Development of shelf-stable reagents and assay kits for bioluminescence applications using the capillary-assisted vitrification platform stabilization technology
PLOS One · 05.11.2026 · 21 (11) · e0354533
DOI: 10.1371/journal.pone.0354533 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 05.11.2026. Verfasst von Shari Radford und 14 weiteren Autor:innen. Beteiligte Einrichtung: Ambient Biosciences, Ann Arbor, Michigan, United States of America. Hauptthemen laut MEDLINE: Luminescent Measurements, Vitrification. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ambient Biosciences and Promega Corp..
Abstract (Originalsprache)
Luminescence is a powerful method for detecting trace analytes and monitoring biological processes. However, most bioluminescence reagents, including luciferase and its substrates, are sensitive to temperature, limiting their usable shelf lives, and resulting in inconsistent performance. Enhancing the stability of these reagents could reduce signal variability between experiments, simplify workflows, and address cold chain storage issues. In this study, we demonstrate the application of the platform stabilization technology, capillary-assisted vitrification (CAV), as a tool to stabilize different luciferases and their substrates, and the application of the stabilized reagents in both in vitro and in vivo bioluminescent assays. We demonstrate that CAV-stabilized reagents can be stored and shipped ambiently, maintain consistent performance over time, and are suitable for use in cell viability quantification, tumor monitoring, in vivo imaging, microbial detection, and immunoassays. Additionally, different reagents can be co-formulated to make ready-to-use assay kits that can also be shipped and stored ambiently. Our results demonstrate that CAV stabilization is a viable alternative to traditional storage methods, with broad potential to improve bioluminescence workflows.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ambient Biosciences, Ann Arbor, Michigan, United States of America.
- Promega Corp., Madison, Wisconsin, United States of America.
- Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee, United States of America.
- Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee, United States of America.
- Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
ORCID-Profile: Shari Radford, Mary Shank-Retzlaff, Laura L Bronsart
Förderung
- Ambient Biosciences and Promega Corp.
Zitieren
APA
Radford, S., Peris-Taverner, Y., Dibble, M., Corn, K., Zhu, T., Martello, S., Mayeaux, M., Ladd, A., Renu, S., Chunduri, T., Jadhav, A., Dart, M., Rafat, M., Shank-Retzlaff, M., & Bronsart, L. L. (2026). Development of shelf-stable reagents and assay kits for bioluminescence applications using the capillary-assisted vitrification platform stabilization technology. PLOS One, 21(11), e0354533. https://doi.org/10.1371/journal.pone.0354533
Vancouver
Radford S, Peris-Taverner Y, Dibble M, Corn K, Zhu T, Martello S, et al. Development of shelf-stable reagents and assay kits for bioluminescence applications using the capillary-assisted vitrification platform stabilization technology. PLOS One. 2026;21(11):e0354533. doi:10.1371/journal.pone.0354533
BibTeX
@article{Radford2026,
author = {Radford, Shari and Peris-Taverner, Yolanda and Dibble, Michael and Corn, Kevin and Zhu, Tian and Martello, Shannon and Mayeaux, McKenzie and Ladd, Amanda and Renu, Sankar and Chunduri, Tejasvi and Jadhav, Aniket and Dart, Melanie and Rafat, Marjan and Shank-Retzlaff, Mary and Bronsart, Laura L},
title = {Development of shelf-stable reagents and assay kits for bioluminescence applications using the capillary-assisted vitrification platform stabilization technology},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0354533},
doi = {10.1371/journal.pone.0354533}
}
EUVIMED